Range
- - -
Vol / Avg.
-/537.3K
Div / Yield
-
52 Wk
1.49 - 5.29
Mkt Cap
85.3M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.23
Shares
46.4M
Outstanding
46.4M
Total Float
43.1M
load more
Sector: Health Care.Industry: Pharmaceuticals
Recro Pharma Inc is a contract development and manufacturing company. The company is engaged in the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose drug products. Its product portfolio includes Ritalin LA, Focalin XR, Verelan PM, SR & Verapamil PM, Verapamil SR, and Zohydro ER.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-13
REV
Q1 2021Est.ActualSurprise
EPS-0.250-0.230 0.0200
REV16.430M16.803M373.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
REPHRecro Pharma-1.09%85.3M

Recro Pharma Frequently Asked Questions

Q

How do I buy Recro Pharma (REPH) stock?

A

You can purchase shares of Recro Pharma (NASDAQ: REPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Recro Pharma's (REPH) competitors?

Q

What is the target price for Recro Pharma (REPH) stock?

A

The latest price target for Recro Pharma (NASDAQ: REPH) was reported by Oppenheimer on May 12, 2020. The analyst firm set a price target for 12.00 expecting REPH to rise to within 12 months (a possible 552.17% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Recro Pharma (REPH)?

A

The stock price for Recro Pharma (NASDAQ: REPH) is $1.84 last updated Thu Jul 29 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Recro Pharma (REPH) pay a dividend?

A

There are no upcoming dividends for Recro Pharma.

Q

When is Recro Pharma (NASDAQ:REPH) reporting earnings?

A
Recro Pharma’s Q2 earnings are confirmed for after-market on August 13, 2021.
Q

Is Recro Pharma (REPH) going to split?

A

There is no upcoming split for Recro Pharma.

Q

What sector and industry does Recro Pharma (REPH) operate in?

A

Recro Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.